Patent Drop
The sneaker drop calendar — but for your medicine going generic.
Drug patent expirations, generic arrivals, and the 2026 "Patent Cliff" — translated into beautiful, plain-language consumer content with countdowns, savings estimates, and science explainers
Niche Explored
Drug Patent Expirations & The 2026 “Patent Cliff” — tracking when blockbuster drugs lose patent protection and affordable generics/biosimilars arrive. Consumer-facing, plain-language coverage of the $140B+ patent cliff.
Existing Competition
- DrugPatentWatch (drugpatentwatch.com) — Industry/professional tool. Paywalled, enterprise pricing ($3K+/yr). Dense, not consumer-friendly. No visual appeal.
- GoodRx — Price comparison, but doesn’t deeply cover upcoming patent expirations or the science behind generics. Consumer-facing but focuses on current deals, not the pipeline.
- GreyB (greyb.com/blog/drug-patents-expiring-2026/) — One-off blog posts listing expiring patents. IP firm marketing. Dry, not a regular publication.
- IntuitionLabs — Similar one-off articles. AI-generated, generic tone.
- Drug Discovery News — Industry publication, not consumer-facing.
- NPR — Occasional pieces (March 2026 article on prescription drug shopping).
KEY GAP
Nobody is doing this for regular people. No site treats patent expirations as exciting events with countdowns, savings calculators, and plain-language explainers. The data is public (FDA) but locked behind bureaucratic formats. Massive opportunity to be the “consumer translator” of pharma patent data.
Data Sources Found
Primary (Free, Automatable)
- FDA Orange Book Data Files — URL: https://www.fda.gov/drugs/drug-approvals-and-databases/orange-book-data-files — Free downloadable .ZIP files with patent expiration dates, exclusivity data, therapeutic equivalence ratings. Updated monthly. Tab-delimited format.
- openFDA Drug Label API — URL: https://open.fda.gov/apis/drug/label/ — Free, no API key needed for basic use (1000 requests/day without key, 120K/day with key). Drug labeling data, indications, warnings, active ingredients.
- openFDA Drug Adverse Event API — URL: https://open.fda.gov/apis/drug/event/ — FAERS database. Free. Can query adverse events for brand vs generic comparisons.
- ClinicalTrials.gov API v2 — URL: https://clinicaltrials.gov/data-api/api — Free, no key. 500K+ trials. Can search for generic/biosimilar clinical trials in progress.
- CrossRef REST API — URL: https://api.crossref.org — Free. 140M+ indexed works. Can find recent research papers on specific drug generics, bioequivalence studies.
- PubMed/NCBI E-utilities — URL: https://eutils.ncbi.nlm.nih.gov — Free (with API key for higher rate). Search biomedical literature for generic equivalence studies, pharmacokinetic data.
- FDA Drug Approvals API — URL: https://open.fda.gov/apis/drug/drugsfda/ — Track new generic/biosimilar approvals as they happen.
Secondary
- Medicare Drug Spending Dashboard — CMS.gov, public data on drug spending.
- WHO Essential Medicines List — Cross-reference for global importance.
- Apify FDA Orange Book Scraper — Pre-built scraper for structured data extraction.
SEO Analysis
- Keywords with high volume, low competition:
- “when does [drug name] go generic” — Searched millions of times. Currently answered by scattered forum posts and pharma PR.
- “generic [drug name] release date 2026” — Very specific, high intent.
- “Keytruda patent expiration” — Keytruda = $25B/year drug. Patent expiring 2028.
- “Eliquis generic 2026” — One of the most-prescribed drugs in the US.
- “Stelara biosimilar 2025 2026” — J&J’s biggest drug, going off-patent.
- “affordable alternatives to [drug]” — Evergreen, high intent.
- Search volume signals: “drug patent cliff 2026” trending heavily. 54+ drugs face patent expiration 2026-2027 per DrugPatentWatch. $140B+ in annual revenue at risk.
- Content gap: No consumer-friendly, visually rich, regularly updated site covers this niche. Current results are either paywalled (DrugPatentWatch), one-off articles (GreyB), or dense government data.
Communities
- r/pharmacy — 340K+ members
- r/medicine — 670K+ members
- r/HealthInsurance — 130K+ members
- r/ChronicIllness — 150K+ members
- r/Ozempic, r/diabetes, r/rheumatoid — Disease-specific subs where people talk about drug costs
- Patient advocacy Facebook groups — Millions of members across conditions
- Twitter/X #PatentCliff, #GenericDrugs — Active pharma discussion
- Telegram pharmacy/health channels
Image/Graphic Feasibility
- Countdown timers — Visual patent expiration countdowns (easy to generate as SVG/canvas)
- Savings calculators — Brand vs generic price comparison charts (data from openFDA + scraping)
- Patent timeline visualizations — Interactive/static timelines showing when each drug goes off-patent
- Molecule diagrams — AI-generated molecular structure illustrations
- “Drop cards” — Product-launch-style cards for each generic arrival (like sneaker drop announcements)
- Data charts — D3.js or Chart.js for spending data, price trends, adverse event comparisons
- Maps — Pharmacy price heat maps by region (if pricing data available)
Sources
- https://www.fda.gov/drugs/drug-approvals-and-databases/orange-book-data-files
- https://open.fda.gov/apis/drug/label/
- https://open.fda.gov/apis/drug/event/
- https://clinicaltrials.gov/data-api/api
- https://www.drugpatentwatch.com/p/expiring-drug-patents-generic-entry/
- https://www.drugdiscoverynews.com/blockbuster-drugs-face-a-massive-patent-cliff-in-2026-17019
- https://www.greyb.com/blog/drug-patents-expiring-2026/
- https://www.wprx.com/news/post-patent-pricing-new-2026-generics
- https://www.npr.org/2026/03/29/nx-s1-5724143/prescription-drug-shopping-deals
- https://github.com/FDA/openfda